DeDe Sheel | Vice President-Investor Relations |
Peter Greenleaf | President and Chief Executive Officer |
Joe Miller | Chief Financial Officer |
Neil Solomons | Chief Medical Officer |
Ed Arce | HC Wainwright |
Justin Kim | Oppenheimer |
Olivia Brayer | Cantor Fitzgerald |
Sahil Dhingra | RBC |
Greetings, and welcome to Aurinia Pharmaceuticals Second Quarter 2022 Financial and Operational Results Conference Call. At this time all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host DeDe Sheel, Aurinia's Vice President of Investor Relations.